Keros Therapeutics CEO Jasbir Seehra's 2020 pay jumps 1,268% to $9.5M
Keros Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 19, 2021
Keros Therapeutics reported fiscal year 2020 executive compensation information on April 19, 2021.
In 2020, three executives at Keros Therapeutics received on average a compensation package of $5.1M, a 826% increase compared to previous year.
Average pay of disclosed executives at Keros Therapeutics
Jasbir Seehra, Chief Executive Officer, received $9.5M in total, which increased by 1,268% compared to 2019. 92% of Seehra's compensation, or $8.7M, was in option awards. Seehra also received $263K in non-equity incentive plan, $521K in salary, as well as $3.5K in other compensation.
Jennifer Lachey, Chief Scientific Officer, received a compensation package of $3.5M, which increased by 755% compared to previous year. 85% of the compensation package, or $3M, was in option awards.
Keith Regnante, Chief Financial Officer, earned $2.4M in 2020.
Related executives
You may also like
Source: SEC filing on April 19, 2021.